Notably, TOP2A, LRRC58, HAUS6, SMC4, ACVRL1, and KPNB1 were identified as m6A-modified genes associated with CRC recurrence, thereby serving as a promising predictive biomarker panel or therapeutic target for patients with CRC recurrence. The gene discussed is SMC4; the disease is colorectal carcinoma.